Case number 2:23-cv-03020
BAYER INTELLECTUAL PROPERTY GMBH et al v. AUSON PHARMACEUTICALS INC. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 5, 2023 | 17 | Order of MDL Panel transferring case to the District of District of Delaware. (krg) (Entered: 10/05/2023) (3) |
| Oct 2, 2023 | 16 | Notice of Request by Pro Hac Vice HOWARD S. SUH to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14754001.) (KALISH, PAUL) (Entered: 10/02/2023) (2) |
| Sep 29, 2023 | 15 | ORDER granting Defendants' 12 Application for Howard S. Suh, Esq. to appear pro hac vice. Signed by Magistrate Judge Leda D. Wettre on 9/29/2023. (mxw) (Entered: 09/29/2023) (3) |
| Sep 28, 2023 | 12 | APPLICATION/PETITION by AUSON PHARMACEUTICALS CO., LTD., AUSON PHARMACEUTICALS INC.. (Attachments: # 1 Declaration of Howard S. Suh in Support of Pro Hac Vice Admission, # 2 Certification of Paul W. Kalish in Support of Pro Hac Vice Admission, # 3 Text of Proposed Order on Consent Granting Pro Hac Vice Application)(KALISH, PAUL) Modified on 9/28/2023 (mxw). (Entered: 09/28/2023) (0) |
| Sep 28, 2023 | 13 | NOTICE of Appearance by GERARD P. NORTON on behalf of AUSON PHARMACEUTICALS CO., LTD., AUSON PHARMACEUTICALS INC. (NORTON, GERARD) (Entered: 09/28/2023) (2) |
| Sep 28, 2023 | 14 | NOTICE of Appearance by JONATHAN R. LAGARENNE on behalf of AUSON PHARMACEUTICALS CO., LTD., AUSON PHARMACEUTICALS INC. (LAGARENNE, JONATHAN) (Entered: 09/28/2023) (2) |
| Sep 22, 2023 | 10 | ANSWER to Complaint with Affirmative Defenses, COUNTERCLAIM against BAYER AG, BAYER INTELLECTUAL PROPERTY GMBH, BAYER PHARMA AG, JANSSEN PHARMACEUTICALS, INC. by AUSON PHARMACEUTICALS CO., LTD., AUSON PHARMACEUTICALS INC.. (Attachments: # 1 Exhibit A)(KALISH, PAUL) (Entered: 09/22/2023) (0) |
| Sep 22, 2023 | 11 | Corporate Disclosure Statement by AUSON PHARMACEUTICALS CO., LTD., AUSON PHARMACEUTICALS INC. identifying SHANGHAI AUSON PHARMACEUTICALS CO., LTD as Corporate Parent.. (KALISH, PAUL) (Entered: 09/22/2023) (3) |
| Sep 21, 2023 | 9 | NOTICE of Appearance by PAUL W. KALISH on behalf of AUSON PHARMACEUTICALS CO., LTD., AUSON PHARMACEUTICALS INC. (KALISH, PAUL) (Entered: 09/21/2023) (2) |
| Aug 17, 2023 | 8 | NOTICE that pursuant to the order of the United States Judicial Panel on Multidistrict Litigation filed on August 11, 2023, a hearing session has been scheduled to consider various matters under 28 U.S.C. § 1407 on September 28, 2023 at the University of Kentucky (see Section B of attached notice). (krg, ) (Entered: 08/17/2023) (10) |
| Jul 26, 2023 | 6 | WAIVER OF SERVICE Returned Executed by JANSSEN PHARMACEUTICALS, INC., BAYER INTELLECTUAL PROPERTY GMBH, BAYER AG, BAYER PHARMA AG. AUSON PHARMACEUTICALS CO., LTD. waiver sent on 7/24/2023, answer due 9/22/2023. (MILLER, KEITH) (Entered: 07/26/2023) (1) |
| Jul 26, 2023 | 7 | WAIVER OF SERVICE Returned Executed by JANSSEN PHARMACEUTICALS, INC., BAYER INTELLECTUAL PROPERTY GMBH, BAYER AG, BAYER PHARMA AG. AUSON PHARMACEUTICALS INC. waiver sent on 7/24/2023, answer due 9/22/2023. (MILLER, KEITH) (Entered: 07/26/2023) (1) |
| Jun 5, 2023 | 4 | Corporate Disclosure Statement by JANSSEN PHARMACEUTICALS, INC. identifying JOHNSON & JOHNSON as Corporate Parent.. (MILLER, KEITH) (Entered: 06/05/2023) (2) |
| Jun 5, 2023 | 5 | Corporate Disclosure Statement by BAYER AG, BAYER INTELLECTUAL PROPERTY GMBH, BAYER PHARMA AG identifying BAYER AG as Corporate Parent.. (MILLER, KEITH) (Entered: 06/05/2023) (2) |
| Jun 2, 2023 | 2 | AO120 Patent/Trademark Form filed. (Attachments: # 1 Complaint) (mxw) (Entered: 06/02/2023) (0) |
| Jun 2, 2023 | 3 | SUMMONS ISSUED as to AUSON PHARMACEUTICALS CO., LTD., AUSON PHARMACEUTICALS INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (mxw, ) (Entered: 06/02/2023) (2) |
| Jun 1, 2023 | 1 | Complaint* (1) |
